Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes

AIDS

Volumn 15, Issue 8, 2001, Pages 965-974

  Costa, Paola ^a   Rusconi, Stefano ^d   Mavilio, Domenico ^d   Fogli, Manuela ^b   Murdaca, Giuseppe ^d   Pende, Daniela ^a   Mingari, Maria Cristina ^d   Galli, Massimo ^d   Moretta, Lorenzo ^b   De Maria, Andrea ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d NONE

Author keywords

CD8 T lymphocytes; Cytotoxic T lymphocytes; HAART; HIV 1; HLA; Inhibitory NK receptors; KIR

Indexed keywords

ANTIRETROVIRUS AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD94 ANTIGEN; CELL RECEPTOR; HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INHIBITION;

ADULT; ANTIGENS, CD; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VIRUS REPLICATION;

EID: 0035947098     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200105250-00004     Document Type: Article

References (36)

1. 1. Furrer H, Egger M, Opravil M, et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. N Engl J Med 1999, 340:1301-1306.
2. 2. Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2000, 342:1416-1428.
3. 3. Zaunders JJ, Cunningham PH, Kelleher AD, et al. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1): partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis 1999, 180:320-329.
4. 4. Fleury S, Rizzardi GP, Chapuis A, et al. Long-term kinetics of T cell production in Hiv-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci USA 2000, 97:5393-5398.
5. 5. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
6. 6. Malhotra U, Berrey MM, Huang Y, et al. Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type I. J Infect Dis 2000, 181: 121-131.
7. 7. Connick E, Lederman MM, Kotzin BL, et al.. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 2000, 181: 358-363.
8. 8. Pitcher CJ, Quittner C, Peterson DM, et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Med 1999, 5:518-525.
9. 9. Hellerstein M, Hanky MB, Cesar D, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med 1999, 5:83-9.
10. 10. Pantaleo G, De Maria A, Koenig S, et al. CD8+ T lymphocytes of patients with AIDS maintain normal broasd cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity, Proc Natl Acad Sci USA 1990, 87:4818-4822.
11. 11. Bisset LR, Cone RW, Huber W, et al. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS 1998, 12:2115-2123.
12. 12. Soudeyns H, Campi G, Rizzardi P, et al.. Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor β chain repertoire and reduces the level of T-cell oligoclonality. Blood 2000, 95: 1743-1751.
13. 13. Harrigan PR, Whaley M, Montaner JS. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy, AIDS 1999, 13(suppl 8):F59-F62.
14. 14. Garcia F, Plana M, Vidal C, et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 1999, 13(suppl 8):F79-F86.
15. 15. Chun TW, Engel D, Mizell SB, et al.. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nature Med 1999, 5:651-655.
16. 16. Davey RT Jr, Bhat N, Yoder C, et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci USA 1999, 96:15109-15114.
17. 17. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med 1999, 5:512-517.
18. 18. Zhang L, Ramratnam B, Tenner-Racz K, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999, 340:1605-1613.
19. 19. Hockett RD, Kilby JM, Derdeyn CA, et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 1999, 189: 1545-1554.
20. 20. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific Cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279:2103-2106.
21. 21. Gray CM, Lawrence J, Schapiro JM, et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 1999, 162:1780-1788.
22. 22. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus-specific circulating T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules ofr T-cell activation. J Virol 2000, 74:7320-7330.
23. 23. Trimble LA, Lieberman J. Circulating CD8 Tlymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 1998, 91: 585-594.
24. 24. De Maria A, Ferraris A, Guastella M, et al. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc Natl Acad Sci USA 1997, 94:10285-10288.
25. 25. De Maria A, Moretta L. HLA-class I-specific inhibitory receptors in HIV-1 infection. Hum Immunol 2000, 61:74-81.
26. 26. De Maria A, Mavilio D, Costa P, Dignerti P, Fogli M, Mingari MC. Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection. Immunol Lett 2000, 72:179-182.
27. 27. Mingari MC, Ponte M, Bertone S, et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998, 95:1172-1177.
28. 28. Pende D, Biassoni R, Cantoni C, et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996, 184:505-518.
29. 29. Seventh Workshop and Conference on Human Leukocyte Differentiation Antigens. Harrogate, June 2000.
30. 30. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 2000, 74:1648-1657.
31. 31. Mingari MC, Schiavetti F, Ponte M, et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell population. Proc Natl Acad Sci USA 1996, 93:12433.
32. 32. Zinkernagel RM. Immunology taught by viruses. Science 1996, 271:173-178.
33. 33. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Immunol Today 2000, 21:447-464.
34. 34. Orendi JM, Bloem AC, Borleffs JC, et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998, 178:1279-1287.
35. 35. Bertone S, Schiavetti F, Bellomo R, et al.: Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol 1999, 29:23.
36. 36. Huard B, Karlsson L. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement. Nature 2000, 403:325-328.